GlaxoSmithKline has become embroiled in a corruption probe concerning some of its Chinese staff, but its first-half numbers helped to soothe market nerves. Lex's Julia Grindell and Oliver Ralph discuss the UK drugmaker's results and the importance of China to the business. For more video content from the Financial Times, visit http://www.FT.com/video
Category
🗞
News